Literature DB >> 12561454

Reverse-engineering clinical biology. A peacetime dividend yields drug trials on virtual patients.

Gary Stix.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12561454

Source DB:  PubMed          Journal:  Sci Am        ISSN: 0036-8733            Impact factor:   2.142


× No keyword cloud information.
  1 in total

Review 1.  Strategic challenges in neurotherapeutic pharmaceutical development.

Authors:  Christopher C Gallen
Journal:  NeuroRx       Date:  2004-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.